blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2371837

EP2371837 - Novel immunogenic compositions for the prevention and treatment of meningococcal disease [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.07.2017
Database last updated on 30.09.2024
Most recent event   Tooltip13.07.2018Lapse of the patent in a contracting state
New state(s): CY, MC, TR		published on 15.08.2018  [2018/33]
Applicant(s)For all designated states
Wyeth Holdings LLC
235 East 42nd Street
New York, NY 10017-5755 / US
[2016/38]
Former [2014/10]For all designated states
Wyeth Holdings LLC
235 East 42nd Street
New York, NY 10017-5755 / US
Former [2013/51]For all designated states
Wyeth Holdings LLC
Five Giralda Farms
Madison, NJ 07940 / US
Former [2011/40]For all designated states
Wyeth Holdings Corporation
Five Giralda Farms
Madison, NJ 07940 / US
Inventor(s)01 / Zlotnick Gary, W.
21 Woodlyn Way
Penfield NY 14526 / US
02 / Fletcher, Leah, D.
37 Second Street
Geneseo, NY 14454 / US
03 / Farley John
49 Evandale Road
Rochester, NY 14618 / US
04 / Bernfield, Liesel, A.
789 Thurston Road
Rochester, NY 14619 / US
05 / Zagursky Robert, J
569 Fox Hunt Drive
Victor, NY 14564 / US
06 / Metcalf, Benjamin, J.
15 Rensselaer Drive
Rochester, NY 14618 / US
 [2011/40]
Representative(s)Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
[2012/33]
Former [2011/40]Ricol, David Gerard, et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Application number, filing date10182544.611.10.2002
[2011/40]
Priority number, dateUS20010328101P11.10.2001         Original published format: US 328101 P
US20020406934P30.08.2002         Original published format: US 406934 P
[2011/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2371837
Date:05.10.2011
Language:EN
[2011/40]
Type: B1 Patent specification 
No.:EP2371837
Date:21.09.2016
Language:EN
[2016/38]
Search report(s)(Supplementary) European search report - dispatched on:EP18.08.2011
ClassificationIPC:C07K1/00, C07K2/00, A61K39/02, A61K39/095, A61K38/00, A61K39/00, C07K16/12, C07K14/22, G01N33/569, C12N9/28, C12N9/40, C12N9/38, A61K39/39, A61K47/48
[2016/20]
CPC:
A61K39/095 (EP,CN,KR,US); A61K39/39 (US); A61K47/543 (EP,US);
A61K47/646 (EP,US); A61P25/00 (EP); A61P31/04 (EP);
A61P37/04 (EP); C07K14/22 (EP,US); C07K16/1217 (EP,US);
C12N9/2417 (EP,US); C12N9/2465 (EP,US); C12N9/2471 (EP,US);
G01N33/56911 (EP,US); A61K2039/505 (EP,US); A61K2039/523 (CN);
A61K2039/53 (EP,US); A61K2039/54 (US); A61K2039/55505 (CN,US);
A61K2039/55572 (EP,US); A61K2039/55577 (EP,US); A61K2039/58 (EP,US);
A61K2039/6087 (US); A61K39/00 (EP,CN,KR,US); G01N2333/22 (EP,US);
Y10S530/825 (EP,US) (-)
Former IPC [2011/40]C07K1/00, C07K2/00, A61K39/02, A61K39/095, A61K38/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2016/38]
Former [2011/40]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  SK,  TR 
TitleGerman:Neue immunogene Zusammensetzungen zur Prävention und Behandlung der Meningokokken-Erkrankung[2011/40]
English:Novel immunogenic compositions for the prevention and treatment of meningococcal disease[2011/40]
French:Nouvelles compositions immunogènes pour la prévention et le traitement de la méningite à méningocoques[2011/40]
Examination procedure27.03.2012Amendment by applicant (claims and/or description)
05.04.2012Examination requested  [2012/20]
24.05.2012Despatch of a communication from the examining division (Time limit: M06)
07.11.2012Reply to a communication from the examining division
07.01.2013Observations by third parties
04.04.2013Despatch of a communication from the examining division (Time limit: M06)
14.10.2013Reply to a communication from the examining division
24.02.2015Despatch of a communication from the examining division (Time limit: M06)
26.08.2015Reply to a communication from the examining division
28.04.2016Communication of intention to grant the patent
09.08.2016Fee for grant paid
09.08.2016Fee for publishing/printing paid
09.08.2016Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP02804818.9  / EP1442047
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20020804818) is  20.09.2007
Opposition(s)22.06.2017No opposition filed within time limit [2017/35]
Fees paidRenewal fee
15.10.2010Renewal fee patent year 03
15.10.2010Renewal fee patent year 04
15.10.2010Renewal fee patent year 05
15.10.2010Renewal fee patent year 06
15.10.2010Renewal fee patent year 07
15.10.2010Renewal fee patent year 08
15.10.2010Renewal fee patent year 09
31.10.2011Renewal fee patent year 10
31.10.2012Renewal fee patent year 11
31.10.2013Renewal fee patent year 12
31.10.2014Renewal fee patent year 13
02.11.2015Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT21.09.2016
BE21.09.2016
CY21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
MC21.09.2016
NL21.09.2016
SE21.09.2016
SK21.09.2016
TR21.09.2016
LU11.10.2016
CH31.10.2016
LI31.10.2016
BG21.12.2016
GR22.12.2016
PT23.01.2017
[2018/29]
Former [2017/41]AT21.09.2016
BE21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
NL21.09.2016
SE21.09.2016
SK21.09.2016
LU11.10.2016
CH31.10.2016
LI31.10.2016
BG21.12.2016
GR22.12.2016
PT23.01.2017
Former [2017/35]AT21.09.2016
BE21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
NL21.09.2016
SE21.09.2016
SK21.09.2016
CH31.10.2016
LI31.10.2016
BG21.12.2016
GR22.12.2016
PT23.01.2017
Former [2017/34]AT21.09.2016
BE21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
NL21.09.2016
SE21.09.2016
SK21.09.2016
BG21.12.2016
GR22.12.2016
PT23.01.2017
Former [2017/23]AT21.09.2016
BE21.09.2016
CZ21.09.2016
EE21.09.2016
FI21.09.2016
NL21.09.2016
SE21.09.2016
SK21.09.2016
BG21.12.2016
GR22.12.2016
PT23.01.2017
Former [2017/23]AT21.09.2016
BE21.09.2016
CZ21.09.2016
EE21.09.2016
FI21.09.2016
NL21.09.2016
SE21.09.2016
SK21.09.2016
BG21.12.2016
GR22.12.2016
Former [2017/13]FI21.09.2016
NL21.09.2016
SE21.09.2016
BE31.10.2016
GR22.12.2016
Former [2017/12]FI21.09.2016
SE21.09.2016
BE31.10.2016
GR22.12.2016
Former [2017/10]FI21.09.2016
SE21.09.2016
BE31.10.2016
Documents cited:Search[X]WO0164922  (CHIRON SPA [IT], et al);
 [X]WO0164920  (CHIRON SPA [IT], et al);
by applicantUS4376110
 EP0125023
 US4554101
 EP0171496
 EP0173494
 WO8601533
 EP0178220
 EP0184187
 EP0185573
 US4650764
 EP0232262
 US4797368
 WO8907150
 US4861719
 WO9002806
 CA2012311
 US4980289
 EP0453242
 WO9118088
 WO9205263
 EP0488528
 US5124263
 US5139941
 WO9309239
 WO9412649
 WO9421807
 WO9426914
 WO9428152
 WO9428938
 WO9502697
 WO9507358
 US5399346
 WO9518863
 WO9521931
 WO9522617
 WO9526411
 US5459127
 WO9528494
 WO9610038
 WO9617823
 WO9622378
 WO9625508
 US5580859
 US5583038
 WO9639036
 US5589466
 WO9719182
 US5739118
 WO9901157
 WO9901158
 WO9901175
 US5955580
 WO0018434
 US6130085
 US6355253
 WO1986US02269
otherWO9957280
 WO03020756
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.